Verastem Inc (VSTM) Stock Analysis

Verastem Inc (VSTM) is a publicly traded company in the HEALTHCARE sector. It trades at $3.81, carries a market capitalization of $368.19M. This page summarizes the public market data, fundamentals, and frequently asked questions for VSTM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Verastem Inc currently has a Neutral sentiment score of 0.07.

About Verastem Inc

Verastem Inc. is a clinical-stage biopharmaceutical company headquartered in Needham, Massachusetts, dedicated to developing and commercializing innovative therapies for patients battling cancer. With a particular focus on addressing unmet medical needs through its proprietary drug candidates, Verastem aims to enhance the quality of life and improve clinical outcomes for cancer patients. The company's robust pipeline includes targeted therapies designed to overcome treatment resistance and im...

GNG Research Analysis

GNG Research scores Verastem Inc (VSTM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VSTM.

Frequently Asked Questions

Does VSTM pay dividends?

Verastem Inc (VSTM) does not currently pay a regular dividend.

What is VSTM's market cap?

Verastem Inc (VSTM) has a market capitalization of $368.19M with a current stock price of $3.81.